Regulation of prescription medicines in Australia

Closed/historical consultations and reviews

These documents remain on this website for historical reference.

• A discussion paper on regulation of extemporaneously prepared medicines in non-hospital pharmacies
  <http://www.tga.gov.au/meds/extempcomp2.htm>
  closed 23 May 2008
• Second discussion paper: Improving access to Consumer Medicines Information (CMI) and Product Information (PI)
  <http://www.tga.gov.au/meds/accesspmi2.htm>
  closed 30 March 2007
• Revision of the Australian code of good wholesaling practice for therapeutic goods for human use
  <http://www.tga.gov.au/consult/2006/cgwp-dr.htm>
  closed 11 August 2006
• Workflow practices within the Drug Safety and Evaluation Branch
  <http://www.tga.gov.au/pmeds/dsebworkflow.htm>
  May 2006
• Public access to information contained in ARTG entries for therapeutic goods
  <http://www.tga.gov.au/consult/2005/artgaccess.htm>
  closed 3 February 2006
• Review of the need for further regulation of extemporaneous compounding
  <http://www.tga.gov.au/meds/extempcomp.htm>
  September 2005
• Report to Health Ministers on a cost-benefit analysis of pharmacist only (S3) and pharmacy medicines (S2) and risk-based evaluation of the standards
  <http://www.tga.gov.au/meds/s2s3report.htm>
  August 2005
• Regulatory impact statement for a price information code of practice
  <http://www.tga.gov.au/meds/rispicop.htm>
  4 August 2005
• Improving access to prescription medicines information
  <http://www.tga.gov.au/consult/2005/accesspmi.htm>
  closed 27 June 2005